Literature DB >> 23820862

Culture, science and the changing nature of fibromyalgia.

Frederick Wolfe1, Brian Walitt.   

Abstract

Fibromyalgia is a common but contested illness. Its definition and content have changed repeatedly in the 110 years of its existence. The most important change was the requirement for multiple tender points and extensive pain that arose in the 1980s, features that were not required previously. By 2010, a second shift occurred that excluded tender points, allowed less extensive pain, and placed reliance on patient-reported somatic symptoms and cognitive difficulties ('fibro fog') that had never been part of past definitions or content. Fibromyalgia is closely allied with and often indistinguishable from neurasthenia, a disorder of the late 19th and early 20th centuries that lost favour when it was perceived as being a psychological illness. Fibromyalgia's status as a 'real disease', rather than a psychocultural illness, is buttressed by social forces that include support from official criteria, patient and professional organizations, pharmaceutical companies, disability access, and the legal and academic communities.

Entities:  

Mesh:

Year:  2013        PMID: 23820862     DOI: 10.1038/nrrheum.2013.96

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  44 in total

1.  A Lecture on Lumbago: Its Lessons and Analogues: Delivered at the National Hospital for the Paralysed and Epileptic.

Authors:  W R Gowers
Journal:  Br Med J       Date:  1904-01-16

Review 2.  The social construction of illness: key insights and policy implications.

Authors:  Peter Conrad; Kristin K Barker
Journal:  J Health Soc Behav       Date:  2010

3.  Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects.

Authors:  H Moldofsky; P Scarisbrick; R England; H Smythe
Journal:  Psychosom Med       Date:  1975 Jul-Aug       Impact factor: 4.312

Review 4.  Fibromyalgia wars.

Authors:  Frederick Wolfe
Journal:  J Rheumatol       Date:  2009-04       Impact factor: 4.666

5.  Railway spine revisited: traumatic neurosis or neurotrauma?

Authors:  T Keller
Journal:  J Hist Med Allied Sci       Date:  1995-10       Impact factor: 2.088

6.  Fibrositis.

Authors:  E F Traut
Journal:  J Am Geriatr Soc       Date:  1968-05       Impact factor: 5.562

7.  Death of neurasthenia and its psychological reincarnation: a study of neurasthenia at the National Hospital for the Relief and Cure of the Paralysed and Epileptic, Queen Square, London, 1870-1932.

Authors:  R E Taylor
Journal:  Br J Psychiatry       Date:  2001-12       Impact factor: 9.319

8.  Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population.

Authors:  Frederick Wolfe; Elmar Brähler; Andreas Hinz; Winfried Häuser
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-05       Impact factor: 4.794

9.  The difficult doctor-patient relationship: somatization, personality and psychopathology.

Authors:  S R Hahn; K S Thompson; T A Wills; V Stern; N S Budner
Journal:  J Clin Epidemiol       Date:  1994-06       Impact factor: 6.437

10.  EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.

Authors:  Frederick Wolfe; Kaleb Michaud; Tracy Li; Robert S Katz
Journal:  J Rheumatol       Date:  2009-12-23       Impact factor: 4.666

View more
  25 in total

1.  Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients.

Authors:  Winfried Häuser; Eva-Maria Hoffmann; Frederick Wolfe; Angus B Worthing; Neil Stahl; Russell Rothenberg; Brian Walitt
Journal:  Clin Exp Rheumatol       Date:  2015-03-18       Impact factor: 4.473

2.  Implication of invalidation concept in fibromyalgia diagnosis.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Sepehr Tohidi; Irandokht Shenavar; Ehsan Kazemnezhad Leyli; Kazem Hosseini; Mohammad-Javad Khosousi
Journal:  Clin Rheumatol       Date:  2021-01-07       Impact factor: 2.980

3.  Behaviour change interventions targeting physical activity in adults with fibromyalgia: a systematic review.

Authors:  Tom O'Dwyer; Sinead Maguire; David Mockler; Laura Durcan; Fiona Wilson
Journal:  Rheumatol Int       Date:  2019-03-12       Impact factor: 2.631

4.  Perceived injustice in fibromyalgia and rheumatoid arthritis.

Authors:  Robert Ferrari; Anthony Science Russell
Journal:  Clin Rheumatol       Date:  2014-03-04       Impact factor: 2.980

5.  The Work of Workplace Disclosure: Invisible Chronic Conditions and Opportunities for Design.

Authors:  Kausalya Ganesh; Amanda Lazar
Journal:  Proc ACM Hum Comput Interact       Date:  2021-04

Review 6.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

7.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

Review 8.  Two sides on the fibromyalgia coin: physical pain and social pain (invalidation).

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari
Journal:  Clin Rheumatol       Date:  2020-08-09       Impact factor: 2.980

9.  Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Subjects.

Authors:  Xiao Zhang; Huji Xu; Zhiyi Zhang; Yang Li; Lynne Pauer; Shanmei Liao; Fengchun Zhang
Journal:  J Pain Res       Date:  2021-02-25       Impact factor: 3.133

10.  Towards a neurophysiological signature for fibromyalgia.

Authors:  Marina López-Solà; Choong-Wan Woo; Jesus Pujol; Joan Deus; Ben J Harrison; Jordi Monfort; Tor D Wager
Journal:  Pain       Date:  2017-01       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.